Feedback / Questions
Gazyva (obinutuzumab) - Roche, Biogen
Gazyva: Regulatory submissions in US/EU for SLE in 2026
(Roche)
-
Apr 24, 2025 -
Q1 2025 Results
EMA filing • FDA filing
•
Systemic Lupus Erythematosus
https://assets.roche.com/f/176343/x/0cd9054dc9/irp250424.pdf
Apr 24, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious